Integral Diagnostics (IDX.AX) Earnings Analysis
Integral Diagnostics (IDX.AX) next reports earnings on 2026-08-25, consensus EPS 0.06389 AUD. Last quarter (2025-08-25) it missed with EPS 0.01362 AUD vs 0.06017 AUD est (-77.4%). It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E 55.05.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does IDX.AX next report earnings?
| Next earnings date | 2026-08-25 |
|---|---|
| Consensus EPS estimate | 0.06389 AUD |
| Revenue estimate | 0.40B |
IDX.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-25 | 0.01362 AUD | 0.06017 AUD | -77.4% | Miss |
Beat rate: 0/1 (0%) over reported quarters with consensus data.
IDX.AX valuation and analyst view
| Trailing P/E | 55.05 |
|---|---|
| Trailing EPS | 0.03764 AUD |
| Price / book | 1.14 |
| Dividend yield | 3.53% |
| Market cap | 0.77B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Integral Diagnostics (IDX.AX)'s next earnings date?
Integral Diagnostics is next scheduled to report on 2026-08-25, with a consensus EPS estimate of 0.06389 AUD and revenue estimate of 0.40B.
Did IDX.AX beat earnings last quarter?
In its 2025-08-25 report, IDX.AX posted EPS of 0.01362 AUD versus a 0.06017 AUD estimate — a miss of 77.4%.
What is IDX.AX's earnings track record?
Over the last 1 reported quarters with consensus data, IDX.AX beat estimates 0 times (0%).
What is IDX.AX's current P/E ratio and EPS?
IDX.AX trades at a trailing P/E of 55.05 on trailing EPS of 0.037635360657673034 AUD.
What do analysts rate IDX.AX?
IDX.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.